Update shared on 03 Nov 2025
Fair value Increased 6.84%Analysts have raised their price target for Neuland Laboratories from ₹16,375 to ₹17,494.50. This change reflects updated expectations based on modest adjustments in forecasted revenue growth, profit margin, and valuation multiples.
What's in the News
- Board meeting scheduled on November 7, 2025, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2025 (Key Developments).
- Special/Extraordinary Shareholders Meeting on November 5, 2025, to consider re-designation of Mr. Davuluri Sucheth Rao as executive vice chairman and Mr. Davuluri Saharsh Rao as chief executive officer and managing director (Key Developments).
- Board meeting on September 23, 2025, to review modifications to the roles and responsibilities of the Executive Leadership, effective April 1, 2026 (Key Developments).
- Special/Extraordinary Shareholders Meeting on September 26, 2025, to approve the appointment of Dr. Ravi Shankar Gopinath as an Independent Director (Key Developments).
Valuation Changes
- Consensus Analyst Price Target has increased from ₹16,375 to ₹17,494.50, reflecting a higher fair value assessment.
- Discount Rate remains unchanged at 12.73%.
- Revenue Growth estimates have slipped slightly from 31.21% to 30.81%.
- Net Profit Margin projections have decreased marginally from 23.33% to 23.20%.
- Future P/E ratio has risen from 40.16x to 43.54x, which indicates higher expected valuation multiples.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.